Cancer immunotherapy: Strategies for personalization and combinatorial approaches.
about
Towards tumor immunodiagnosticsToll-like receptor agonist therapy can profoundly augment the antitumor activity of adoptively transferred CD8(+) T cells without host preconditioning.The importance for immunoregulation for long-term cancer control.Addressing intra-tumoral heterogeneity and therapy resistance.Resistance to anticancer immunity in cancer patients: potential strategies to reverse resistance.Dendritic Cell Strategies for Eliciting Mutation-Derived Tumor Antigen Responses in Patients.Immune Surveillance Plays a Role in Locally Aggressive Giant Cell Lesions of Bone.T-cell immunoglobulin mucin 3 blockade drives an antitumor immune response in head and neck cancer.Predictors of responses to immune checkpoint blockade in advanced melanomaImmunotherapy and gene therapy as novel treatments for cancer.New Strategies Using Antibody Combinations to Increase Cancer Treatment Effectiveness.Establishment and genomic characterizations of patient-derived esophageal squamous cell carcinoma xenograft models using biopsies for treatment optimization.Mechanisms of Immune Evasion and Immune Modulation by Lymphoma Cells.Importance of immune monitoring approaches and the use of immune checkpoints for the treatment of diffuse intrinsic pontine glioma: From bench to clinic and vice versa (Review).Current status and future directions of cancer immunotherapy.Evolution of Therapeutic Antibodies, Influenza Virus Biology, Influenza, and Influenza Immunotherapy.CTLA-4 and PD-1 Ligand Gene Expression in Epithelial Thyroid Cancers
P2860
Q26738691-DEC89075-64F5-4ED7-93C5-40F568878B66Q36583710-DD5B2DB2-83B3-4011-8284-0AD9E139A209Q38647002-43ECF781-79E1-4790-9469-2765D021F146Q38823179-E66F0135-C5A7-4561-B4F0-AA81DB99B07AQ39013616-5DCF3F7F-C155-422D-B622-227565D9FA71Q39243064-53FEF35C-6D7C-4D81-9A9B-F80B577E250DQ39446788-A8085AB7-BA95-4CB2-AC99-9F1CDA90BF55Q41127889-744B4292-99F2-4AE2-9A88-8E77F0908CE5Q41701241-6A7C1057-2BB9-4297-9542-09471CED856FQ45875535-AC4C4B68-537D-4047-AAE3-CD96C97FBEDAQ47221234-862ADA63-0AAC-41BC-B674-217C0562C6E4Q48164333-28B4ED1E-7AC2-4B45-AB79-CB4379F88D29Q52643503-CE6E1BD8-8DF9-4869-81B4-CE44073D74A2Q52683991-1124B221-4063-4DB0-90FF-36D5112A8E11Q55070491-A9827FC1-9063-464B-B536-62885AA80AEDQ55554478-0EA435C2-CD30-4382-AD6F-B1BC5BC0C29EQ56891239-E5173F9F-67E8-447E-8C2D-9BF2125E15AD
P2860
Cancer immunotherapy: Strategies for personalization and combinatorial approaches.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Cancer immunotherapy: Strategies for personalization and combinatorial approaches.
@ast
Cancer immunotherapy: Strategies for personalization and combinatorial approaches.
@en
type
label
Cancer immunotherapy: Strategies for personalization and combinatorial approaches.
@ast
Cancer immunotherapy: Strategies for personalization and combinatorial approaches.
@en
prefLabel
Cancer immunotherapy: Strategies for personalization and combinatorial approaches.
@ast
Cancer immunotherapy: Strategies for personalization and combinatorial approaches.
@en
P2860
P1433
P1476
Cancer immunotherapy: Strategies for personalization and combinatorial approaches.
@en
P2093
Sattva S Neelapu
Vishwanath Sathyanarayanan
P2860
P304
P356
10.1016/J.MOLONC.2015.10.009
P577
2015-10-23T00:00:00Z